The study proposes a novel post-TBI (TBI-common among AD patients 20–30%) mechanism of A2AR activation that triggers Tau hyperphosphorylation, causing memory impairment which may be normalized by chronic caffeine administration [60]. The gene discussed is ADORA2A; the disease is Alzheimer disease.